Last update 23 Jan 2025

Runer Ophthalmic Drugs (Guangzhou) Co., Ltd.

Private Company|
2020|
Guangdong Sheng, China

Overview

Tags

Otorhinolaryngologic Diseases
Immune System Diseases
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases1
Immune System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
H1 receptor(Histamine H1 receptor)1

Related

1
Drugs associated with Runer Ophthalmic Drugs (Guangzhou) Co., Ltd.
Epinastine Hydrochloride
Target
H1 receptor
Mechanism
H1 receptor antagonists
Active Org.
Nippon Boehringer Ingelheim Co., Ltd. [+5]
Originator Org.
Boehringer Ingelheim GmbHBoehringer Ingelheim GmbH
Active Indication
Conjunctivitis, Allergic [+9]
Inactive Indication
Dermatitis, Atopic [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date01 Apr 1994
2
Clinical Trials associated with Runer Ophthalmic Drugs (Guangzhou) Co., Ltd.
CTR20242221
/ Not yet recruitingPhase 2
一项评价ZOC2017217滴眼液在老年性白内障患者中有效性和安全性的多中心、随机、双盲、阳性药对照的II期临床研究
[Translation] A multicenter, randomized, double-blind, active-controlled Phase II clinical study to evaluate the efficacy and safety of ZOC2017217 eye drops in patients with senile cataract
CTR20231572
/ CompletedPhase 3
0.05%盐酸依匹斯汀滴眼液治疗中国过敏性结膜炎患者的有效性和安全性的随机、双盲、阳性药平行对照、多中心临床研究
[Translation] A randomized, double-blind, positive-drug parallel-controlled, multicenter clinical study on the efficacy and safety of 0.05% epinastine hydrochloride eye drops in the treatment of allergic conjunctivitis in Chinese patients
100 Clinical Results associated with Runer Ophthalmic Drugs (Guangzhou) Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Runer Ophthalmic Drugs (Guangzhou) Co., Ltd.
Login to view more data
100 Deals associated with Runer Ophthalmic Drugs (Guangzhou) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Runer Ophthalmic Drugs (Guangzhou) Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Epinastine Hydrochloride
 ( H1 receptor )		Conjunctivitis, Allergic
More
Phase 3
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free